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Canine Insulinoma 
Dave Jordan* 
R. W. Carithers, DVMt 
Hypoglycemia in a dog due to an in-
sulinoma was first reported in the literature in 
1927. Although there have been many 
reported cases since that time. it is still 
considered to be a fairly rare condition by 
most authors. Its frequency. however. is 
probably much greater than the literature 
would lead one to believe. as the vast majority 
of cases go unreported or unrecognized. The 
Iowa State University Teaching Hospital 
alone diagnoses three or four cases each year. 
which is a substantial number in light of the 
fact that functional beta cell tumors have 
been reported in only 45 dogs. 7 
The hallmark of this syndrome is a "mature 
onset" hypoglycemia. which results from the 
excessive production and inappropriate 
secretion of insulin from the neoplastic beta 
cells. 
The maintenance of blood glucose con-
centration (normally 70 to 110 mg/dl in the 
dog) depends upon several factors: (1) 
adequate intake and absorption of nutrients. 
(2) normal liver function. and (3) the syn-
thesis and release. in appropriate amounts. of 
insulin. cortisol. glucagon. epinephrine. and 
growth hormone. II Thus a hypoglycemic 
condition or episode has several possible 
etiologies which must be considered; it is but 
the sign of a more specific defect somewhere 
in the complex blood glucose homeostatic 
system. 
As a diagnostic aid. the causes of 
hypoglycemia may be divided into two 
categories. One group includes those 
problems related to intestinal absorption 
and/or hepatic production of glucose; i.e .• 
where an inadequate amount of glucose is 
being provided to the blood. Chronic star-
vation or malabsorption. glycogen storage 
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diseases in the young ("juvenile onset" 
hypoglycemia). and acute or chronic liver 
failure are in this group. (It should be noted, 
however, that although hepatic disease can be 
responsible for a hypoglycemia. the function 
to maintain blood glucose concentration is 
usually not lost unless the entire liver is in-
volved. II such that other signs would likely 
appear before and predominate over the 
hypoglycemic state.) 
The second group involves those problems 
which lead to an increased rate of removal of 
glucose from the blood; i.e.. increased 
peripheral utilization of glucose. (In man. 
renal tubular glycosuria must also be con-
sidered. but this condition. although it occurs 
in the dog, has not been shown to be 
associated with hypoglycemia. 7) It is this 
effect which leads to a hypoglycemia in the 
case of insulinomas, insulin overdose. or 
posioning with sulfonylurea compounds, such 
as tolbutymide (which apparently act by 
stimulating the release of insulin from the 
beta cells). In these cases, the peripheral 
glucose utilization is primarily in the form of 
glycogen deposition and lipogenesis. The 
functional hypoglycemia seen in hunting dogs 
may also be included in this group, as the 
hypoglycemic episodes are precipitated by 
strenuous muscular exercise, hence an in-
creased peripheral glucose utilization, but in 
this case via glycolysis (increased energy 
demands). However. there are some who feel 
that this malady has as its underlying etiology 
some type of glycogen storage deficiency. 7 
The presenting signs associated with a 
hypoglycemia. regardless of etiology. are 
those of a neurologic dysfunction- a 
reflection of the great dependency of the 
central nervous system upon blood glucose 
concentration. Two factors are responsible 
for this dependency: (1) the unavailability of 
glycogen stores and (2) the fact that neurons 
rely upon passive diffusion for their glucose 
supply; i.e.. insulin is not involved. The 
severity of the signs seen is said to be more 
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dependent upon the rate at which blood 
glucose concentration declines than upon the 
actual degree of hypoglycemia,7 indicating 
that there is some ability for the brain to 
adapt to low blood glucose levels. This helps 
to explain the variability and progression of 
symptoms reported by the owners of in-
sulinoma dogs. It also explains why in-
sulinoma dogs, when presented for clinical 
examination, may appear normal in every 
respect and yet frequently have blood glucose 
concentrations which are well below the 
normal range. 
The functional disturbances charac-
teristically reported in insulinoma cases are 
episodic in nature, occurring initially at 
widely spaced intervals which become more 
frequent and severe as the condition 
progresses, until grand mal-type seizures may 
be an almost daily event. 1 Early signs 
frequently reported include weakness, 
particularly of the hindquarters, fatigue after 
exercise, trembling, generalized muscular 
twitching, changeable temperament, in-
coordination and ataxia_ In more advanced 
cases, confusion and disorientation or ap-
parent blindness, retching, vomiting, and 
tono-clonic consulvions, often lasting 10 to 15 
minutes or more are commonly seen. 
However, in some cases there may be no 
history of any type of dysfunction prior to the 
onset of seizure activity, and the dog will be 
completely normal between episodes, while in 
other cases there may be no history of seizures 
at all. 1.2.5.6.7.9 
If recurrent seizures are included in the 
history, and they usually are, several dif-
ferential diagnoses must be included. These 
include idiopathic' epilepsy, brain tumor, 
encephalitis, lead posioning, hypoparathy-
roidism, and cardiovascular or respiratory 
diseases which could lead to cerebral ischemia 
(which can cause seizures) as well as 
hypoglycemia.6,7 Causes of seizures outside 
the nervous system should be eliminated 
before causes inside the nervous system are 
sought. 6 The physical exam should reveal 
f!vidence of cardiovascular or respiratory 
disease, such as arrhythmias, murmurs, 
ascites, or dyspnea. The history should in-
dicate whether or not access to lead might be 
a possibility. Blood or urine lead level 
determinations are necessary for con-
firmation. Hypoparathyroidism, an ex-
tremely rare disease in the dog,7 can be ruled 
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out based on the analysis of blood calcium 
and phosphorus levels. 
Unfortunately, hypoglycemia in general, 
and insulinoma in particular, cannot be as 
easily ruled out, nor ruled in, as the cause for 
recurrent seizures simply on the basis of a 
single blood glucose determination. A dog 
with an actively secreting beta cell tumor, if 
in an apprehensive and excited state when 
brought into the exam room, may have 
enough of an epinephrine response to elevate 
the blood glucose level to well into the normal 
range. Moreover, a dog with idiopathic 
epilepsy or a brain tumor may be found to be 
hypoglycemic, as this is not an uncommon 
incidental finding during routine screening of 
mature dogs. 7 This is not to say that a fasting 
blood glucose determination is not a valuable 
diagnostic aid as long as it is interpreted as 
suggestive evidence rather than proof. In-
deed, a fasting blood glucose concentration of 
less than 40 mg/ dl is adequate for a 
presumptive diagnosis of insulinoma in an 
adult dog suffering from recurrent seizures. 
In some cases a 48 hour fast may be necessary 
to see glucose levels fall that low, but usually a 
12 to 24 hour fast is adequate. It is always a 
good idea to repeat the test three times before 
deciding whether or not more provocative 
tests are indicated. The best time to draw 
blood for the test is early in the morning, 
when the dog is quiet. 
The history can also provide some im-
portant differentiating clues, which can be 
especially helpful in determining what further 
course be followed for the diagnosis of cases 
where the results of the fasting glucose tests 
are questionable. It is important to ascertain 
the duration and progression of signs, as 
insulinoma dogs frequently have long 
histories of neurologic disturbances. Also, 
there is frequently a common pattern to the 
occurrence of seizures in that they are often 
associated with fasting periods (such as early 
in the morning, before feeding), exercise, or 
in many cases closely following a meal, as 
carbohydrates and some amino acids act as a 
stimulus for insulin release. The age of the 
animal is also important, as insulinomas 
occur most frequently in older dogs, the 
average age being about nine years.7 
The best tests available today for con-
firming a diagnosis of insulinoma are the 
glucagon tolerance test, the insulin 
radioimmunoassay, and the high-dose in-
71 
travenous glucose tolerance test (H-IVGTT). 
Very low glucose concentrations (less than 40 
mg/dl) in three consecutive fasting blood 
glucose determinations can also be considered 
nearly pathognomonic. Other tests used in 
the past have been discounted due to dangers 
involved with their use or their inability to 
positively differentiate insulinomas from 
other causes of hypoglycemia.2.7·9 Although 
the H-IVGTT is useful for evaluating the 
ability of an animal to shift glucose out of the 
plasma space, the results obtained with this 
test in cases of insulinomas are not as con-
sistent as those obtained with the glucagon 
tolerance test. This is because the H-IVGTT 
depends upon an acute outpouring of insulin 
from the neoplastic beta cells in response to 
the hyperglycemia created by rapid in-
travenous injection of glucose (1 Gm/Kg of 
body weight). This does not always occur.· 2 
Glucagon, on the other hand,. provokes the 
release of insulin both directly (within three 
minutes after intravenous injection) and 
indirectly via its rapid glycogenolytic effect 
(15 to 30 minutes after injection). 7 
The glucagon tolerance test is preferably 
run after a 12 hour fast. An IV dose of 0.03 
mg glucagon/kg of body weight is ad-
ministered after blood is drawn for a 
preinjection blood glucose evaluation. Blood 
glucose concentration is then determined for 
samples taken at 1, 3, 5, 15, 30, 45, 60, 90, 
120 and 180 minutes. An exaggerated insulin 
response is expected if the patient has a 
functional beta cell tumor. Peak blood 
glucose concentrations will usually not exceed 
140 mg/dl, whereas normal dogs will peak in 
the range of 180 to 200 mg/dl. More im-
portantly, the neoplastic outpouring of in-
sulin causes a much more rapid fall in blood 
glucose levels, . such that a profound 
hypoglycemia (less than 50 mg/ dl) occurs 45 
to 90 minutes after administration. 2.4.7 
Seizures may accompany the hypoglycemia, 
so glucose should be available for intravenous 
administration. In normal dogs, the blood 
glucose concentration will decline more 
slowly, remaining elevated for more than two 
hours.2 
The newest test for the positive diagnosis of 
insulinoma is the insulin radioimmunoassay 
(insulin-RIA), in which plasma insulin levels 
are determined directly. The normal fasting 
level is about 20 uU/ml; insulinoma dogs 
usually have values of over 50 uU/ml. 2 In 
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fasting hypoglycemia due to other causes, 
such as malabsorption, plasma insulin levels 
are usually normal to subnormal. 7 The in-
sulin to glucose ratio is thus the most im-
portant criterion of the test, as it is a 
statement of cause and effect. Im-
munoreactive insulin concentrations 
determined for samples drawn during a 
glucagon tolerance test will give dramatic 
evidence, which is clearly diagnostic, of this 
cause and effect relationship. 7 
In mail., up to 90% of insulinomas are 
benign. In the dog, the majority are 
malignant.' These carcinomas are usually 
large, multilobular, and invade extensively 
into the adjacent parenchyma and lym-
phatics. The establishment of metastases in 
extra pancreatic sites, including lymph nodes, 
liver, mesentery, and omentum, occurs early 
in the disease, frequently before the diagnosis 
can be made. (The early phases of the disease 
are masked by an increased secretion of the 
anti-insulin hormones- glucocorticoids, glu-
cagon, epinephrine and STH.IO) As a result, 
eliminating the source of the excess insulin via 
surgical extirpation of the pancreatic lesion, 
which would obviously be the treatment of 
choice, is not often possible. 
In cases in which the hyperinsulinism is due 
to a single functional adenoma, surgical 
removal of the portion of the pancreas 
cont~ining the neoplastic tissue can result in a 
dramatic amelioration of the hypoglycemia 
and its attendant signs, unless there have been 
irreversible changes in the CNS. 12 In contrast 
to carcinomas, adenomas are sharply 
delineated and encapsulated, making suc-
cessful surgical excision possible.' They can 
mobilize, however, so it is wise to check the 
entire pancreas to detect other tumors. 
Although the neoplasm is usually of 
significant size to be palpable and observable, 
in some cases the tumor cannot be identified 
during the exploratory laparotomy, and in 
these cases, a total pancreatectomy would be 
required. Although this is not a difficult 
procedure, the owner should be forewarned 
of the necessity for special diets and insulin 
and, pancreatic enzyme supplementation, 
which will be required for the remainder of 
the animal's life. J Other important con-
siderations are that postsurgical com-
plications, such as pancreatitis, are common, 
and that the older age of the dog may make 
the patient a poor surgical risk. 
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During and immediately after the surgical 
procedure, it is important to maintain a 
continuous IV drip of 5 or 10 percent dextrose 
solution, as well as continuously monitoring 
the blood glucose level, since palpation of the 
tumor may result in considerable insulin 
release. 3 •12 Since postsurgical idiopathic 
hyperthermia has been observed, cor-
ticosteroids prior to surgery are recommended 
as prophylaxis. 7.12 
Postsurgically, the partial pancreatectomy 
patient may become hyperglycemic for a few 
hours or days. Two possible reasons are (1) an 
excess of anti-insulin hormones and/or (2) 
depression of the secretory activity of the non-
neoplastic beta cells in the remainder of the 
pancreas due to long term suppression by the 
elevated insulin levels. 1 Postsurgical care is 
directed primarily toward prevention of 
pancreatitis and consists of food restriction, 
the administration of corticosteroids and 
parasympatholytic agents, and parenteral 
fluid therapy. I. 12 Serum amylase activity is 
useful as an indicator of the severity of 
postsurgical pancreatitis, but some elevation 
can be expected to occur for 7 to 10 days. 1 
Lymph node enlargement and yellow-white 
foci in the liver are suggestive of metastasis of 
islet cell carcinomas. Although the prognosis 
in such a case is poor, a total pancreatectomy 
may be of some benefit in prolonging the life 
of the patient, as the carcinomas tend to be 
slow growing. 1 Dietary management is very 
important, as glucose and some amino acids 
stimulate insulin secretion, whereas lipids do 
not. Therefore the diet should include fats as 
the main source of energy, well-balanced 
protein just adequate to meet maintenance 
requirements, and minimal amounts of 
carbohydrates. Diazoxide and hydrochloro-
thiazide are hyperglycemic agents which may 
be useful for symptomatic treatment in 
metastasized cases or in cases where surgery is 
not advisable or desired. Frequent feedings 
are also helpful in controlling hypoglycemia. 
Conclusion 
Although canine insulinoma is considered 
to be a fairly rare condition, its occurrence is 
frequent enough that it should be included in 
the differential diagnosis anytime a dog is 
presented with a history of recurrent seizures. 
Also, it is important that an adequate battery 
of tests be used before the condition is ruled 
out. This should include at least three fasting 
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blood glucose determinations, followed by a 
glucagon tolerance test or high-dose in-
travenous glucose tolerance test, preferably in 
combination with an insulin radioim-
munoassay for positive diagnosis in question-
able cases. 
Early diagnosis is of paramount importance 
if surgical excision of the tumor is to be 
curative; in most cases, due to the high in-
cidence of malignancy and early metastasis, it 
is only palliative. Yet despite the poor long-
term prognosis, proper home care, including 
dietary management and the use of 
hyperglycemic drugs, coupled with surgery 
when possible, can extend life for a 
reasonable period of time. Before any course 
of therapy is instituted, the owner should be 
educated as to the possible complications of 
surgery, the high incidence of malignancy, 
and the trouble and expense involved with 
maintenance of the patient following pan-
createctomy. 
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